Abeona Therapeutics Inc
F:PCJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abeona Therapeutics Inc
F:PCJ
|
US |
|
S
|
Sino Land Co Ltd
XMUN:SNO
|
HK |
|
M
|
MSCI Inc
F:3HM
|
US |
|
N
|
National Grid PLC
DUS:NNGF
|
UK |
|
Mercedes Benz Group AG
F:DAII
|
DE |
Wall St Price Targets
PCJ Price Targets Summary
Abeona Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for PCJ is 16.868 EUR with a low forecast of 11.861 EUR and a high forecast of 24.662 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PCJ's stock price target?
Price Target
16.868
EUR
According to Wall Street analysts, the average 1-year price target for PCJ is 16.868 EUR with a low forecast of 11.861 EUR and a high forecast of 24.662 EUR.
What is the Revenue forecast for Abeona Therapeutics Inc?
Projected CAGR
233%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 233%.
What is the Gross Profit forecast for Abeona Therapeutics Inc?
Projected CAGR
280%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 280%.
What is the Pre-Tax Income forecast for Abeona Therapeutics Inc?
Projected CAGR
-22%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -22%.
What is the Net Income forecast for Abeona Therapeutics Inc?
Projected CAGR
-20%
The compound annual growth rate for Net Income over the next 3 years is -20%.
